David Clair | Senior Director, IR and Corporate Development |
Chuck Kummeth | CEO |
Jim Hippel | CFO |
Dan Arias | Stifel |
Puneet Souda | SVB Securities |
Jacob Johnson | Stephens |
Alex Nowak | Craig-Hallum |
Catherine Schulte | Baird |
Patrick Donnelly | Citi |
Paul Knight | KeyBanc |
00:04 Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Third Quarter of Fiscal Year 2022. At this time, all participants have been placed in listen-only mode and the call will be opened for questions following management's prepared remarks.
During our Q&A session, please limit yourself to one question and a follow-up. 00:24 I would now like to turn the call over to David Clair, Bio-Techne's Senior Director, Investor Relations and Corporate Development. Please go ahead, sir.